254 related articles for article (PubMed ID: 8651245)
21. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
Steinke JM; Mauer M;
Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
[TBL] [Abstract][Full Text] [Related]
22. Urinary measurement of transforming growth factor-beta and type IV collagen as new markers of renal injury: application in diabetic nephropathy.
Ellis D; Forrest KY; Erbey J; Orchard TJ
Clin Chem; 1998 May; 44(5):950-6. PubMed ID: 9590367
[TBL] [Abstract][Full Text] [Related]
23. Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function.
Chen CC; Susanto H; Chuang WH; Liu TY; Wang CH
Cardiovasc Diabetol; 2016 Jan; 15():3. PubMed ID: 26739836
[TBL] [Abstract][Full Text] [Related]
24. Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes.
Saraheimo M; Forsblom C; Thorn L; Wadén J; Rosengård-Bärlund M; Heikkilä O; Hietala K; Gordin D; Frystyk J; Flyvbjerg A; Groop PH;
Diabetes Care; 2008 Jun; 31(6):1165-9. PubMed ID: 18346990
[TBL] [Abstract][Full Text] [Related]
25. Captopril acutely lowers albuminuria in normotensive patients with diabetic nephropathy.
Elving LD; Wetzels JF; de Nobel E; Hoitsma AJ; Berden JH
Am J Kidney Dis; 1992 Dec; 20(6):559-63. PubMed ID: 1462982
[TBL] [Abstract][Full Text] [Related]
26. A nation-wide cross-sectional study of urinary albumin excretion rate, arterial blood pressure and blood glucose control in Danish children with type 1 diabetes mellitus. Danish Study Group of Diabetes in Childhood.
Mortensen HB; Marinelli K; Nørgaard K; Main K; Kastrup KW; Ibsen KK; Villumsen J; Parving HH
Diabet Med; 1990 Dec; 7(10):887-97. PubMed ID: 2149686
[TBL] [Abstract][Full Text] [Related]
27. Diabetes complications and glycemic control. The Pittsburgh Prospective Insulin-Dependent Diabetes Cohort Study Status Report after 5 yr of IDDM.
D'Antonio JA; Ellis D; Doft BH; Becker DJ; Drash AL; Kuller LH; Orchard TJ
Diabetes Care; 1989; 12(10):694-70. PubMed ID: 2612304
[TBL] [Abstract][Full Text] [Related]
28. Fish oil in diabetic nephropathy.
Rossing P; Hansen BV; Nielsen FS; Myrup B; Hølmer G; Parving HH
Diabetes Care; 1996 Nov; 19(11):1214-9. PubMed ID: 8908382
[TBL] [Abstract][Full Text] [Related]
29. The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient?
Caramori ML; Fioretto P; Mauer M
Diabetes; 2000 Sep; 49(9):1399-408. PubMed ID: 10969821
[TBL] [Abstract][Full Text] [Related]
30. The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group.
Laffel LM; McGill JB; Gans DJ
Am J Med; 1995 Nov; 99(5):497-504. PubMed ID: 7485207
[TBL] [Abstract][Full Text] [Related]
31. Increased secretion of TGF-beta1 by peripheral blood mononuclear cells from patients with Type 1 diabetes mellitus with diabetic nephropathy.
Korpinen E; Groop PH; Fagerudd JA; Teppo AM; Akerblom HK; Vaarala O
Diabet Med; 2001 Feb; 18(2):121-5. PubMed ID: 11251675
[TBL] [Abstract][Full Text] [Related]
32. The early natural history of nephropathy in Type 1 Diabetes: III. Predictors of 5-year urinary albumin excretion rate patterns in initially normoalbuminuric patients.
Steinke JM; Sinaiko AR; Kramer MS; Suissa S; Chavers BM; Mauer M;
Diabetes; 2005 Jul; 54(7):2164-71. PubMed ID: 15983218
[TBL] [Abstract][Full Text] [Related]
33. Glycemic status, lipid profile and proteinuria in diabetic nephropathy.
Jha P; Das BK; Shrestha S; Majhi S; Chandra L; Sharma S; Baral N
JNMA J Nepal Med Assoc; 2010; 49(178):143-6. PubMed ID: 21485601
[TBL] [Abstract][Full Text] [Related]
34. Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. The EUCLID Study Group.
Lancet; 1997 Jun; 349(9068):1787-92. PubMed ID: 9269212
[TBL] [Abstract][Full Text] [Related]
35. Modulating effect of atorvastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy.
Abdin AA; Hassanien MA; Ibrahim EA; El-Noeman Sel-D
J Diabetes Complications; 2010; 24(5):325-33. PubMed ID: 19553142
[TBL] [Abstract][Full Text] [Related]
36. Relationship of lipoprotein(a) and its phenotypes with the albumin excretion rate in diabetic patients: a multivariate analysis.
Hernández C; Chacón P; Martí R; García-Pascual L; Mesa J; Simó R
Nephron; 2000 May; 85(1):27-33. PubMed ID: 10773752
[TBL] [Abstract][Full Text] [Related]
37. Skeletal muscle lipoprotein-lipase activity in insulin-dependent diabetic patients with and without albuminuria.
Hansen PM; Jensen T; Egeberg J; Lithell H; Kofoed-Enevoldsen A; Deckert T
J Diabetes Complications; 1997; 11(4):230-5. PubMed ID: 9201600
[TBL] [Abstract][Full Text] [Related]
38. Factors associated with progression to macroalbuminuria in microalbuminuric Type 1 diabetic patients: the EURODIAB Prospective Complications Study.
Giorgino F; Laviola L; Cavallo Perin P; Solnica B; Fuller J; Chaturvedi N
Diabetologia; 2004 Jun; 47(6):1020-8. PubMed ID: 15170497
[TBL] [Abstract][Full Text] [Related]
39. Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. The Diabetes Control and Complications (DCCT) Research Group.
Kidney Int; 1995 Jun; 47(6):1703-20. PubMed ID: 7643540
[TBL] [Abstract][Full Text] [Related]
40. High prevalence of risk factors for cardiovascular disease in parents of IDDM patients with albuminuria.
De Cosmo S; Bacci S; Piras GP; Cignarelli M; Placentino G; Margaglione M; Colaizzo D; Di Minno G; Giorgino R; Liuzzi A; Viberti GC
Diabetologia; 1997 Oct; 40(10):1191-6. PubMed ID: 9349601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
